LA
ABBV icon

Lindenwold Advisors’s AbbVie ABBV Stock Holding History

Lindenwold Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$3.62M Buy
15,635
+148
+1% +$30.1K 1.71% 15
2025
Q2 		$2.87M Buy
15,487
+389
+3% +$72.3K 1.49% 19
2025
Q1 		$3.16M Sell
15,098
-314
-2% -$61K 1.76% 17
2024
Q4 		$2.74M Sell
15,412
-328
-2% -$60.3K 1.46% 20
2024
Q3 		$3.11M Buy
15,740
+10
+0.1% +$1.87K 1.57% 18
2024
Q2 		$2.7M Sell
15,730
-57
-0.4% -$9.44K 1.44% 18
2024
Q1 		$2.87M Sell
15,787
-301
-2% -$51.9K 1.54% 19
2023
Q4 		$2.49M Sell
16,088
-52
-0.3% -$7.58K 1.42% 17
2023
Q3 		$2.41M Sell
16,140
-184
-1% -$27K 1.5% 17
2023
Q2 		$2.2M Sell
16,324
-2,362
-13% -$346K 1.35% 21
2023
Q1 		$2.98M Buy
18,686
+375
+2% +$57.3K 1.85% 12
2022
Q4 		$2.96M Buy
18,311
+227
+1% +$34.8K 1.98% 10
2022
Q3 		$2.43M Buy
18,084
+190
+1% +$27.3K 1.8% 13
2022
Q2 		$2.74M Buy
17,894
+193
+1% +$29.5K 1.95% 10
2022
Q1 		$2.87M Buy
17,701
+136
+0.8% +$19.8K 1.76% 12
2021
Q4 		$2.38M Buy
+17,565
New +$2.07M 1.39% 22

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Lindenwold Advisors's ABBV Position: Q3 2025 in Review

Lindenwold Advisors increased its AbbVie (ABBV) stake by 0.96% in Q3 2025, buying an estimated $30.1K and bringing the position to 15,635 shares worth $3.62M. The position accounts for 1.71% of the portfolio, ranked #15.

Lindenwold Advisors first reported a position in ABBV in Q4 2021 and has held it in 16 quarters since. 3,906 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.

  • Lindenwold Advisors held 15,635 shares of AbbVie worth $3.62M as of Q3 2025.
  • Lindenwold Advisors bought 148 AbbVie shares in Q3 2025, an estimated $30.1K.
  • AbbVie made up 1.71% of Lindenwold Advisors's portfolio in Q3 2025, its #15 holding.
  • Lindenwold Advisors first reported a position in AbbVie in Q4 2021 and has held it in 16 quarters since.
  • 3,906 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.

Based on Lindenwold Advisors's 13F filing for Q3 2025, filed 16 Dec 2025.